Summit Therapeutics PLC (SMMT)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 18.43B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 36.91
52W Low
$ 11.76
Dividend Yield
0.00%
Beta
-1.06
Technicals
50-Day MA
25.2928
200-Day MA
21.9565
52 Week High
36.91
52 Week Low
11.76
About SMMT
Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.
Employees
159
Headquarters
Miami, FL
CEO
Mr. Robert W. Duggan
Latest News
SMMT: Car production recovery continues in July - Automotive World
11 hours ago • Google News
What recovery options are there for SMMT - Trade Volume Report & Advanced Swing Trade Entry Plans - Newser
53 minutes ago • Google News